BlackRock’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $233M | Sell |
|
|||||
|
2025
Q2 | $168M | Sell |
|
|||||
|
2025
Q1 | $177M | Sell |
|
|||||
|
2024
Q4 | $151M | Buy |
|
|||||
|
2024
Q3 | $160M | Buy |
|
|||||
|
2024
Q2 | $169M | Buy |
|
|||||
|
2024
Q1 | $175M | Buy |
|
|||||
|
2023
Q4 | $139M | Buy |
|
|||||
|
2023
Q3 | $145M | Buy |
|
|||||
|
2023
Q2 | $115M | Buy |
|
|||||
|
2023
Q1 | $77.1M | Sell |
|
|||||
|
2022
Q4 | $79.8M | Buy |
|
|||||
|
2022
Q3 | $61.9M | Sell |
|
|||||
|
2022
Q2 | $58.7M | Buy |
|
|||||
|
2022
Q1 | $52.1M | Buy |
|
|||||
|
2021
Q4 | $77.7M | Buy |
|
|||||
|
2021
Q3 | $49.6M | Sell |
|
|||||
|
2021
Q2 | $54.2M | Sell |
|
|||||
|
2021
Q1 | $59.7M | Buy |
|
|||||
|
2020
Q4 | $46.2M | Buy |
|
|||||
|
2020
Q3 | $42.7M | Sell |
|
|||||
|
2020
Q2 | $49.4M | Buy |
|
|||||
|
2020
Q1 | $59.4M | Sell |
|
|||||
|
2019
Q4 | $95.5M | Buy |
|
|||||
|
2019
Q3 | $112M | Buy |
|
|||||
|
2019
Q2 | $118M | Buy |
|
|||||
|
2019
Q1 | $95.9M | Sell |
|
|||||
|
2018
Q4 | $61.6M | Sell |
|
|||||
|
2018
Q3 | $78.4M | Sell |
|
|||||
|
2018
Q2 | $92.9M | Buy |
|
|||||
|
2018
Q1 | $75.5M | Buy |
|
|||||
|
2017
Q4 | $82.1M | Buy |
|
|||||
|
2017
Q3 | $66.9M | Buy |
|
|||||
|
2017
Q2 | $54.1M | Buy |
|
|||||
|
2017
Q1 | $56M | Buy |
|
|||||
|
2016
Q4 | $37K | Sell |
|
|||||
|
2016
Q3 | $51K | Buy |
|
|||||
|
2016
Q2 | $36K | Buy |
|
|||||
|
2016
Q1 | $16K | Buy |
|
|||||
|
2015
Q4 | $7K | Hold |
|
|||||
|
2015
Q3 | $6K | Hold |
|
|||||
|
2015
Q2 | $9K | Sell |
|
|||||
|
2015
Q1 | $11K | Hold |
|
|||||
|
2014
Q4 | $10K | Hold |
|
|||||
|
2014
Q3 | $5K | Hold |
|
|||||
|
2014
Q2 | $6K | Buy |
|